BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37321833)

  • 1. Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome.
    Dueñas N; Klinkhammer H; Bonifaci N; Spier I; Mayr A; Hassanin E; Diez-Villanueva A; Moreno V; Pineda M; Maj C; Capellà G; Aretz S; Brunet J
    J Med Genet; 2023 Nov; 60(11):1044-1051. PubMed ID: 37321833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNP association study in PMS2-associated Lynch syndrome.
    Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
    Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence.
    Hassanin E; Spier I; Bobbili DR; Aldisi R; Klinkhammer H; David F; Dueñas N; Hüneburg R; Perne C; Brunet J; Capella G; Nöthen MM; Forstner AJ; Mayr A; Krawitz P; May P; Aretz S; Maj C
    BMC Med Genomics; 2023 Mar; 16(1):42. PubMed ID: 36872334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
    Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS
    Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
    J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers.
    Del Carmen G; Reyes-Uribe L; Goyco D; Evans K; Bowen CM; Kinnison JL; Sepeda VO; Weber DM; Moskowitz J; Mork ME; Thirumurthi S; Lynch PM; Rodriguez-Bigas MA; Taggart MW; You YN; Vilar E
    Front Oncol; 2023; 13():1146825. PubMed ID: 37168379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
    Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C;
    Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.
    Moreira L; Muñoz J; Cuatrecasas M; Quintanilla I; Leoz ML; Carballal S; Ocaña T; López-Cerón M; Pellise M; Castellví-Bel S; Jover R; Andreu M; Carracedo A; Xicola RM; Llor X; Boland CR; Goel A; Castells A; Balaguer F;
    Cancer; 2015 May; 121(9):1395-404. PubMed ID: 25557234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
    Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome.
    Sleiman J; Farha N; Beard J; Bena J; Morrison S; Milicia S; Heald B; Kalady MF; Church J; Liska D; Mankaney G; Burke CA
    Gastrointest Endosc; 2023 Sep; 98(3):412-419.e8. PubMed ID: 37031913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.
    Crain PR; Zepp JM; Gille S; Jenkins L; Kauffman TL; Shuster E; Goddard KAB; Wilfond BS; Hunter JE
    Hered Cancer Clin Pract; 2022 Apr; 20(1):17. PubMed ID: 35436948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Polygenic Risk Scores to Select Screening Intervals After Negative Findings From Colonoscopy.
    Guo F; Weigl K; Carr PR; Heisser T; Jansen L; Knebel P; Chang-Claude J; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2742-2751.e7. PubMed ID: 32376506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption, polygenic risk score, and early- and late-onset colorectal cancer risk.
    Chen X; Li H; Guo F; Hoffmeister M; Brenner H
    EClinicalMedicine; 2022 Jul; 49():101460. PubMed ID: 35747198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
    Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
    J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic anticipation in Swedish Lynch syndrome families.
    von Salomé J; Boonstra PS; Karimi M; Silander G; Stenmark-Askmalm M; Gebre-Medhin S; Aravidis C; Nilbert M; Lindblom A; Lagerstedt-Robinson K
    PLoS Genet; 2017 Oct; 13(10):e1007012. PubMed ID: 29088233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.
    Picó MD; Sánchez-Heras AB; Castillejo A; Giner-Calabuig M; Alustiza M; Sánchez A; Moreira L; Pellise M; Castells A; Llort G; Yagüe C; Ramon Y Cajal T; Gisbert-Beamud A; Cubiella J; Rivas L; Herraiz M; Garau C; Salces I; Carrillo-Palau M; Bujanda L; López-Fernández A; Alvarez-Urturi C; López MJ; Alenda C; Zapater P; Lacueva FJ; Balaguer F; Soto JL; Murcia Ó; Jover R
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Lynch syndrome risk variants in the Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Benonisdottir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Mates IN; Dobra M; Nicolae C; Kristjansdottir S; Jonasson JG; Manolescu A; Arnadottir G; Jensson B; Jonasdottir A; Sigurdsson A; le Roux L; Johannsdottir H; Rafnar T; Halldorsson BV; Jinga V; Stefansson K
    J Cell Mol Med; 2018 Dec; 22(12):6068-6076. PubMed ID: 30324682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.